FBA-27050-31766 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-09-26
Registered in v-safe
2022-12-22
Dose 1 — Pfizer-BioNTech
Co-administered: Flu:Hib:MMR:Polio:Rotavirus
2023-01-27
Dose 2 — Pfizer-BioNTech
2023-04-28
Survey response — 3 months, dose 2, under 3
MedDRA: Croup infectious, Hospitalisation, Influenza, Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit, Hospitalization

MedDRA releases: 2024-11
2023-04-28
Report sent to call center — 3 months, dose 2, under 3
Be unable to work or attend school · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
2023-05-01
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-12-22	Pfizer-BioNTech	Flu:Hib:MMR:Polio:Rotavirus
2	2023-01-27	Pfizer-BioNTech	No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Croup infectious	·	·	✓
SD	Hospitalisation	·	·	✓
SD	Influenza	·	·	✓
SD	Nasopharyngitis	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release